RE: Anomaly19 Nov 2020 13:21
hi Brex. It is easy to think yourself a poor investor when the share is near recent lows! The key here is not to panic, and buy more if you can afford it. What is beyond doubt is that Angle are better situated than they have ever been, with an FDA submission pending, successful cash raises (at 46 and 60p), tight management with a strong short term strategy, which includes a Nasdaq listing. What has befallen the share price is Jupiter fund management being in dire straits and having to force-sell their huge holding. They are nearing the end now, FDA news can come any time in the new year, March most likely, and I would hope that other good announcements will arrive once Jupiter have gone. Chin up!